<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-29533" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Streptococcus pneumoniae</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Dion</surname>
            <given-names>Christopher F.</given-names>
          </name>
          <aff>Mayo Clinic Arizona</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ashurst</surname>
            <given-names>John V.</given-names>
          </name>
          <aff>Kingman Regional Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Christopher Dion declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>John Ashurst declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-29533.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Streptococcus pneumoniae is a gram-positive, lancet-shaped bacterium and a cause of community-acquired pneumonia. Pneumococcal infections are present throughout the world and are most prevalent during the winter and early spring months. This activity outlines the evaluation and treatment of Streptococcus pneumonia infections and reviews the role of interprofessional team members in improving care for those with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the pathophysiology of streptococcus pneumonia.</p></list-item><list-item><p>Review the history and physical exam of a patient with streptococcal pneumonia.</p></list-item><list-item><p>Summarize the treatment options for streptococcal pneumonia.</p></list-item><list-item><p>Explain the importance of cooperation among the interprofessional team in educating patients on the advantages and disadvantages of blood cultures, and compliance with antibiotics to enhance the delivery of care of those with Streptococcus pneumoniae.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29533&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29533">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-29533.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Community-acquired pneumonia (CAP) is the seventh leading cause of death in the United States, and the cost of these hospitalizations is estimated to cost up to $9 billion in the United States (US) dollars each year. Thirty-day hospital mortality associated with CAP has been estimated to be as high as 22% and is the leading cause of death amongst all infectious diseases.</p>
        <p><italic toggle="yes">Streptococcus pneumoniae</italic> is the bacterium that has historically been the most common pathogen to cause CAP worldwide. In the era before antibiotics, <italic toggle="yes">S. pneumoniae</italic> was estimated to be the cause of 95% of all cases of pneumonia. Currently, however, <italic toggle="yes">S. pneumoniae </italic>accounts for up to 15% of pneumonia cases in the United States and 27% of cases worldwide today. Blood cultures are positive in only 20% to 25% of all pneumonia cases that are caused by <italic toggle="yes">S. pneumonia </italic>making it a challenging diagnosis for the clinician.<xref ref-type="bibr" rid="article-29533.r1">[1]</xref><xref ref-type="bibr" rid="article-29533.r2">[2]</xref><xref ref-type="bibr" rid="article-29533.r3">[3]</xref></p>
      </sec>
      <sec id="article-29533.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p><italic toggle="yes">S. pneumonia </italic>was first isolated from the saliva of a patient with rabies in 1881 by Louis Pasteur and the association between lobar pneumonia, and Friedlander and Talamon first reported the bacteria in 1883. Although vaccination efforts were underway as early as 1911, the first pneumococcal vaccine was not produced in the United States until 1977 and the first conjugate vaccine in 2000.<xref ref-type="bibr" rid="article-29533.r4">[4]</xref><xref ref-type="bibr" rid="article-29533.r5">[5]</xref></p>
        <p><italic toggle="yes">S. pneumonia</italic> is a lancet-shaped, gram-positive, facultative anaerobic organism that typically occurs in pairs or short chains. Encapsulated <italic toggle="yes">S. pneumonia </italic>is pathogenic for humans, and the capsular polysaccharide is the basis for which the organism is classified. As of 2011, a total of&#x000a0;92 separate serotypes have been isolated.</p>
      </sec>
      <sec id="article-29533.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Pneumococcal infections are present throughout the world and are most common during the winter and early spring months. IS. pneumoniae is prevalent in large part due to its colonizing ability in the nasopharynx. Almost 40%-50% healthy children and 20%-30% of healthy adults are carriers.<xref ref-type="bibr" rid="article-29533.r6">[6]</xref>&#x000a0;With childhood conjugate vaccination for Streptococcus pneumoniae, the colonization frequency has decreased.</p>
        <p>Although <italic toggle="yes">S. pneumoniae </italic>pneumonia can occur in all populations, it is more common in patients older than 65 years, younger than 2 years, those who smoke, abuse alcohol, have asthma or COPD, or are asplenic. The overall rate of confirmed <italic toggle="yes">S. pneumoniae</italic> infection in the United States is 5.16 to 6.11 cases/100,000 in adults with the rate for those older than 65 years being 36.4/100,000 and infants younger than 1&#x000a0;year being 34.2/100,000.<xref ref-type="bibr" rid="article-29533.r7">[7]</xref><xref ref-type="bibr" rid="article-29533.r8">[8]</xref><xref ref-type="bibr" rid="article-29533.r9">[9]</xref>&#x000a0;World Health Organization estimated that 1.6 million deaths in 2005 including 1 million children less than 5 years of age, occurred due to streptococcus pneumoniae.&#x000a0;It is a common co-infection in influenza patients and affects the morbidity and mortality in such patients.</p>
      </sec>
      <sec id="article-29533.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Infection typically occurs after the colonization of the oropharynx and nasopharynx of healthy individuals. Inhalation of these colonies causes the infection of the lower airways. Infection, typically will not result unless a patient has predisposed risk factors, a bolus of infectious cells or due to a particularly&#x000a0;virulent strain of <italic toggle="yes">S. pneumoniae.</italic></p>
        <p>The capsule plays a major role in the pathogenesis of Streptococcus pneumoniae. It is made up of polysaccharides and surrounds the cell wall. It helps in escaping phagocytosis by preventing the access of granulocytes to the underlying cell wall. These polysaccharides of the capsule help in the identification and serotyping of the bacteria. Many serotypes have been detected, 6, 14, 18, 19 and 23 are the most common ones causing the infection. On culture media, the virulence of these strains can be identified by their appearance, opaque and transparent types. Transparent type usually colonizes in nasopharynx while the opaque type is present in the lung, brain and bloodstream infection.</p>
        <p>The second important characteristic of the pathogenicity of Streptococcus pneumoniae is its ability to adhere to the respiratory epithelium and invasion.&#x000a0;</p>
        <p>The severity of the pneumococcal disease is due to significant inflammatory response induced by the activation of complement pathways and cytokine release by cell wall proteins, autolysin, the capsular polysaccharides and DNA released by bacterial end products.</p>
      </sec>
      <sec id="article-29533.s6" sec-type="Toxicokinetics">
        <title>Toxicokinetics</title>
        <p><italic toggle="yes">S. pneumonia</italic> has several virulence factors that allow it to cause infections in humans. A polysaccharide capsule interferes with phagocytosis by inhibiting the binding of complement C3b to the cell&#x02019;s surface. Pneumococcal proteins also play a large role in the virulence of the bacteria. IgA1 protease interferes with host defense at mucosal surfaces, and neuraminidase prevents the attachment to epithelial cells. Other proteins that act in the virulence of <italic toggle="yes">S. pneumonia</italic> include pneumolysin, pneumococcal surface protein A, and autolysin. Lastly, pili allow for the adherence of the organism to cellular surfaces and play a role in host inflammation.</p>
        <p>Over the last several years, drug-resistant <italic toggle="yes">S. pneumonia</italic> (DRSP) and penicillin-resistant <italic toggle="yes">S. pneumonia</italic> have become more common. Penicillin resistance is the result of alterations in the penicillin-binding protein (PBP) and affects the binding penicillin but not that of all the beta-lactams. DRSP is the result of genetic mutations that can either cause an active efflux of the drug out of the cell or block it from binding. Those at risk of DRSP include the extremes of age, recent antimicrobial therapy, either attending daycare or having a family member who attends daycare, having multiple co-morbid conditions, or being recently hospitalized.</p>
      </sec>
      <sec id="article-29533.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Those with pneumonia may present with a wide array of symptoms, but the most common include dyspnea, cough, pleuritic pain, sputum production, and fever. However, in many studies, these symptoms have been found to neither are sensitive or specific for the diagnosis of pneumonia. In the elderly, the clinical presentation may not follow typical patterns, leading to delay in diagnosis and increased mortality. In the elderly symptoms such as generalized weakness, altered mental status and malaise could be the first signs of the illness.</p>
        <p>A patient&#x02019;s vital signs may be the most useful physical exam finding in diagnosing those with pneumonia. When tachypnea, hypoxia, or hyperthermia is present in a patient whose pneumonia is suspected, further diagnostic evaluation should be undertaken. Classical signs of consolidation such as egophony, rales, whispered pectoriloquy, dullness to percussion or bronchial breath sounds might be heard. However, multiple studies have shown that physical exam findings lack both sensitivity and inter-observer reliability in regards to diagnosing pneumonia.</p>
      </sec>
      <sec id="article-29533.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Routine laboratory evaluation does not aid in diagnosing the organism causing pneumonia but may allow for better risk stratification of patients.<xref ref-type="bibr" rid="article-29533.r10">[10]</xref><xref ref-type="bibr" rid="article-29533.r11">[11]</xref></p>
        <p>Chest radiography has been considered to be the mainstay in diagnosing pneumonia. Classically lobar pneumonia has been taught to be caused by <italic toggle="yes">S. pneumonia</italic>. However new literature has shown that a radiograph is not reliable in determining the causative organism in pneumonia patients. Unfortunately, radiographs are not 100% sensitive in diagnosing pneumonia. Computed tomography (CT) has shown to have better sensitivity and accuracy as compared to plain chest radiography to diagnose CAP but is used limitedly because of a relatively high cost and radiation exposure.</p>
        <p>The diagnosis of the causative organism for pneumonia can be obtained through a variety of means including blood cultures, sputum analysis, and urinary antigens. The routine collection of blood cultures has been controversial in the literature. Recently the Centers for Medicaid and Medicare Services and the Joint Commission on Accreditation of Healthcare Organizations have noted that routine collection of blood cultures is no longer a core measure that is being tracked. Also, the American College of Emergency Physicians (ACEP) made a grade B recommendation against the routine collection of blood cultures in patients admitted with CAP. Further sources note that blood cultures should be obtained in those admitted to the intensive care unit, those with leukopenia, cavitary lesion, severe liver disease, alcohol abuse, asplenia or pleural effusions. When blood cultures are positive, the majority show <italic toggle="yes">S. pneumonia</italic> but rarely change clinical management.</p>
        <p>Sputum cultures typically have had low sensitivity and specificity in detecting the causative organism for pneumonia. However, in those patients suspected of having a drug-resistant organism, sputum cultures should be obtained.</p>
        <p>A urinary antigen does exist to aid the clinician in diagnosing cases of <italic toggle="yes">S. pneumonia</italic> and carries a sensitivity of 80% and a specificity of 97%. However, the usefulness in children is debatable due to many children being carriers of <italic toggle="yes">S. pneumonia. </italic></p>
      </sec>
      <sec id="article-29533.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The mainstay of treatment for patients with <italic toggle="yes">S. pneumonia</italic> is antibiotic therapy and supportive care including mechanical ventilation&#x000a0;if necessary. Treatment of CAP varies based on the area of practice and severity of the disease. Patients with low-risk CAP are typically treated as an outpatient with macrolide monotherapy. Respiratory fluoroquinolones are used in outpatient patients at higher risk. Non-ICU inpatients are treated with a dual therapy of a b-lactam plus a macrolide or respiratory fluoroquinolone monotherapy. Patients admitted to the ICU should be treated with a dual therapy of either a b-lactam plus a macrolide or a b-lactam plus respiratory fluoroquinolone. A recent Cochrane review shows the non-superiority of any outpatient antibiotic regimen for CAP concerning the other drug classes.<xref ref-type="bibr" rid="article-29533.r12">[12]</xref><xref ref-type="bibr" rid="article-29533.r13">[13]</xref><xref ref-type="bibr" rid="article-29533.r14">[14]</xref></p>
        <p>The first dose of antibiotics should be given as quickly as possible after the definitive diagnosis. The ACEP policy statement gives a level B recommendation that there is not enough evidence to establish a benefit in mortality or morbidity from starting the antibiotics in less than 4, 6, or 8 hours. The ACEP clinical policy also notes that there is not enough evidence to determine if there is a benefit in morbidity or mortality from antibiotics being administered within any specific time course but recommends to begin antibiotics as soon as the diagnosis is made. Patients with complicated pneumonia having parapneumonic effusion may need a tube thoracostomy and if it further progresses to empyema and is resistant to drainage by tube thoracostomy then decortication is required with video-assisted thoracoscopic surgery (VATS).</p>
      </sec>
      <sec id="article-29533.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>There are no specific signs and symptoms for pneumococcal pneumonia so whenever the diagnosis of pneumococcal pneumonia is considered following differentials should be kept in mind.</p>
        <list list-type="bullet">
          <list-item>
            <p>Viral pneumonia</p>
          </list-item>
          <list-item>
            <p>PCP</p>
          </list-item>
          <list-item>
            <p>Influenza</p>
          </list-item>
          <list-item>
            <p>Klebsiella pneumonia</p>
          </list-item>
          <list-item>
            <p>Legionella pneumonia</p>
          </list-item>
          <list-item>
            <p>Pleural effusion</p>
          </list-item>
          <list-item>
            <p>Upper respiratory tract infection</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-29533.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Pneumococcal pneumonia, if not treated by appropriate antibiotics at an appropriate time or caused by a more virulent/resistant strains, can lead to the following complications.</p>
        <list list-type="bullet">
          <list-item>
            <p>Necrotizing pneumonia</p>
          </list-item>
          <list-item>
            <p>Lung abscess</p>
          </list-item>
          <list-item>
            <p>Parapneumonic effusion</p>
          </list-item>
          <list-item>
            <p>Empyema</p>
          </list-item>
          <list-item>
            <p>Septicemia, Septic shock</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-29533.s12" sec-type="Consultations">
        <title>Consultations</title>
        <list list-type="bullet">
          <list-item>
            <p>Pulmonary Physician</p>
          </list-item>
          <list-item>
            <p>Infectious disease consultant</p>
          </list-item>
          <list-item>
            <p>Microbiologist</p>
          </list-item>
          <list-item>
            <p>May need an Intensive care physician in severe cases</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-29533.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Universal childhood immunization with a conjugate pneumococcal vaccine should be done. All individuals who are at increased risk of acquiring pneumococcal infection like old age people more than 65 years old, patients with underlying lung disease, alcoholics, with chronic kidney and liver diseases, who are undergoing splenectomy or have functional asplenia should be vaccinated.</p>
        <p>Cigarette smoking has been found to increase the risk of pneumococcal infection in otherwise healthy people. Therefore smoking cessation should be encouraged. Good nutrition, healthy environment and avoidance of daycare attendance decrease the frequency of acquiring the infection.</p>
      </sec>
      <sec id="article-29533.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>There are two vaccines commonly used for <italic toggle="yes">S. pneumoniae. </italic>The pneumococcal polysaccharide vaccine, PPSV23, and the pneumococcal conjugate vaccine, PCV13. In immunocompetent individuals, five doses of PCV13 are recommended during infancy and childhood. A repeat dose of PCV13 at age 65 is recommended followed by a dose of PSV23 one year later. In randomized control trials, PCV13 was shown to prevent the first episode of vaccine-serotype pneumococcal pneumonia. Although these vaccines have made great strides in decreasing <italic toggle="yes">S. pneumoniae </italic>pneumonia, there a number of serotypes not included in these vaccines. Although between the two vaccines the most prevalent serotypes are covered, there are approximately 90 serotypes in total and the vaccine will not foster immunity in all serotypes. Finally, it has been shown that influenza vaccination has a strong association with better outcomes and a decreased rate of pneumonia.</p>
      </sec>
      <sec id="article-29533.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Streptococcal pneumonia is best managed with an interprofessional team that includes a pulmonologist, an infectious disease expert, an ICU nurse, a pharmacist, a respiratory therapist, and a dietitian. Patients need to be educated on the importance of vaccination and its benefits. In addition, patients should be advised to stop smoking and remain compliant with antibiotics. Since many patients with pneumonia are frail, a dietary consult should be sought to help improve the calorie intake. Others may need rehabilitation to restore muscle mass and increase exercise endurance. <xref ref-type="bibr" rid="article-29533.r15">[15]</xref><xref ref-type="bibr" rid="article-29533.r16">[16]</xref>(Level V)</p>
        <p>
<bold>Outcomes</bold>
</p>
        <p>The prognosis for patients with streptococcal pneumonia depends on the underlying risk factors, comorbidity, age, the extent of lung involvement, the need for mechanical ventilation and the type of antibiotic. Overall, the pneumonia is associated with high morbidity and mortality. Even those who survive tend to&#x000a0;have residual deficits in lung mechanics and recovery is prolonged. Patients in the ICU tend to&#x000a0;have the highest mortality approaching 3-20%. <xref ref-type="bibr" rid="article-29533.r1">[1]</xref><xref ref-type="bibr" rid="article-29533.r17">[17]</xref>(level V)</p>
      </sec>
      <sec id="article-29533.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29533&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29533">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/streptococcus-pneumoniae/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=29533">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/29533/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=29533">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-29533.s17">
        <fig id="article-29533.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Streptococcus Pneumoniae example antibiogram Contributed by Zachary Sandman, BA</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="antibiogram" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-29533.s18">
        <title>References</title>
        <ref id="article-29533.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Luna</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Pulido</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Niederman</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Casey</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Burgos</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Leiva Ag&#x000fc;ero</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Grosso</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Membriani</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Entrocassi</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Rodr&#x000ed;quez Fermepin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vay</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Garcia</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Famiglietti</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Decreased relative risk of pneumococcal pneumonia during the last decade, a nested case-control study.</article-title>
            <source>Pneumonia (Nathan)</source>
            <year>2018</year>
            <volume>10</volume>
            <fpage>9</fpage>
            <pub-id pub-id-type="pmid">30263884</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29533.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cill&#x000f3;niz</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Domined&#x000f2;</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Garcia-Vidal</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Torres</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Community-acquired pneumonia as an emergency condition.</article-title>
            <source>Curr Opin Crit Care</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>24</volume>
            <issue>6</issue>
            <fpage>531</fpage>
            <page-range>531-539</page-range>
            <pub-id pub-id-type="pmid">30239410</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29533.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shoji</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>V&#x000e1;zquez-S&#x000e1;nchez</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Gonzalez-Diaz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cubero</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tubau</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a-Somoza</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Li&#x000f1;ares</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yuste</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ardanuy</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Overview of pneumococcal serotypes and genotypes causing diseases in patients with chronic obstructive pulmonary disease in a Spanish hospital between 2013 and 2016.</article-title>
            <source>Infect Drug Resist</source>
            <year>2018</year>
            <volume>11</volume>
            <fpage>1387</fpage>
            <page-range>1387-1400</page-range>
            <pub-id pub-id-type="pmid">30214260</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29533.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Regev-Yochay</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Chowers</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chazan</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gonzalez</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gray</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Pride</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Distribution of 13-Valent pneumococcal conjugate vaccine serotype streptococcus pneumoniae in adults 50&#x000a0;Years and Older presenting with community-acquired pneumonia in Israel.</article-title>
            <source>Hum Vaccin Immunother</source>
            <year>2018</year>
            <volume>14</volume>
            <issue>10</issue>
            <fpage>2527</fpage>
            <page-range>2527-2532</page-range>
            <pub-id pub-id-type="pmid">30188760</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29533.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Quah</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Siau</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>TY</given-names>
              </name>
            </person-group>
            <article-title>Impact of microbial Aetiology on mortality in severe community-acquired pneumonia.</article-title>
            <source>BMC Infect Dis</source>
            <year>2018</year>
            <month>Sep</month>
            <day>04</day>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>451</fpage>
            <pub-id pub-id-type="pmid">30180811</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29533.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ghaffar</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Friedland</surname>
                <given-names>IR</given-names>
              </name>
              <name>
                <surname>McCracken</surname>
                <given-names>GH</given-names>
              </name>
            </person-group>
            <article-title>Dynamics of nasopharyngeal colonization by Streptococcus pneumoniae.</article-title>
            <source>Pediatr Infect Dis J</source>
            <year>1999</year>
            <month>Jul</month>
            <volume>18</volume>
            <issue>7</issue>
            <fpage>638</fpage>
            <page-range>638-46</page-range>
            <pub-id pub-id-type="pmid">10440444</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29533.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alqahtani</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Tashani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ridda</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Gamil</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Booy</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rashid</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Burden of clinical infections due to S. pneumoniae during Hajj: A systematic review.</article-title>
            <source>Vaccine</source>
            <year>2018</year>
            <month>Jul</month>
            <day>16</day>
            <volume>36</volume>
            <issue>30</issue>
            <fpage>4440</fpage>
            <page-range>4440-4446</page-range>
            <pub-id pub-id-type="pmid">29935859</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29533.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wahl</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>O'Brien</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Greenbaum</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Majumder</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Chu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Luk&#x00161;i&#x00107;</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Nair</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>McAllister</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Rudan</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Black</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Knoll</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15.</article-title>
            <source>Lancet Glob Health</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>6</volume>
            <issue>7</issue>
            <fpage>e744</fpage>
            <page-range>e744-e757</page-range>
            <pub-id pub-id-type="pmid">29903376</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29533.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boeddha</surname>
                <given-names>NP</given-names>
              </name>
              <name>
                <surname>Schlapbach</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Driessen</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Herberg</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Rivero-Calle</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Cebey-L&#x000f3;pez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Klobassa</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Philipsen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>de Groot</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Inwald</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Nadel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Paulus</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pinnock</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Secka</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Agbeko</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Berger</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fink</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Carrol</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Zenz</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Levin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>van der Flier</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Martin&#x000f3;n-Torres</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hazelzet</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Emonts</surname>
                <given-names>M</given-names>
              </name>
              <collab>EUCLIDS consortium</collab>
            </person-group>
            <article-title>Mortality and morbidity in community-acquired sepsis in European pediatric intensive care units: a prospective cohort study from the European Childhood Life-threatening Infectious Disease Study (EUCLIDS).</article-title>
            <source>Crit Care</source>
            <year>2018</year>
            <month>May</month>
            <day>31</day>
            <volume>22</volume>
            <issue>1</issue>
            <fpage>143</fpage>
            <pub-id pub-id-type="pmid">29855385</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29533.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bellew</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Grijalva</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Wunderink</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Waterer</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Bramley</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Edwards</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Self</surname>
                <given-names>WH</given-names>
              </name>
            </person-group>
            <article-title>Pneumococcal and Legionella Urinary Antigen Tests in Community-acquired Pneumonia: Prospective Evaluation of Indications for Testing.</article-title>
            <source>Clin Infect Dis</source>
            <year>2019</year>
            <month>May</month>
            <day>30</day>
            <volume>68</volume>
            <issue>12</issue>
            <fpage>2026</fpage>
            <page-range>2026-2033</page-range>
            <pub-id pub-id-type="pmid">30265290</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29533.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ishiguro</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yoshii</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kanauchi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hoshi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Takaku</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kagiyama</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kurashima</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Takayanagi</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Re-evaluation of the etiology and clinical and radiological features of community-acquired lobar pneumonia in adults.</article-title>
            <source>J Infect Chemother</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>24</volume>
            <issue>6</issue>
            <fpage>463</fpage>
            <page-range>463-469</page-range>
            <pub-id pub-id-type="pmid">29605556</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29533.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Osowicki</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Steer</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>International survey of paediatric infectious diseases consultants on the management of community-acquired pneumonia complicated by pleural empyema.</article-title>
            <source>J Paediatr Child Health</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>55</volume>
            <issue>1</issue>
            <fpage>66</fpage>
            <page-range>66-73</page-range>
            <pub-id pub-id-type="pmid">30051535</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29533.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jakhar</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Pandey</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ramachandran</surname>
                <given-names>VG</given-names>
              </name>
              <name>
                <surname>Saha</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Etiology and Risk Factors Determining Poor Outcome of Severe Pneumonia in Under-Five Children.</article-title>
            <source>Indian J Pediatr</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>85</volume>
            <issue>1</issue>
            <fpage>20</fpage>
            <page-range>20-24</page-range>
            <pub-id pub-id-type="pmid">29027126</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29533.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lewandowska</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ku&#x0015b;</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>[Community acquired pneumonia - treatment options according to the international recommendations].</article-title>
            <source>Wiad Lek</source>
            <year>2016</year>
            <volume>69</volume>
            <issue>2 Pt 1</issue>
            <fpage>139</fpage>
            <page-range>139-44</page-range>
            <pub-id pub-id-type="pmid">27421128</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29533.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Green</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Mahajan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bajaj</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>A Simple Approach to Pneumococcal Vaccination in Adults.</article-title>
            <source>J Glob Infect Dis</source>
            <year>2018</year>
            <season>Jul-Sep</season>
            <volume>10</volume>
            <issue>3</issue>
            <fpage>159</fpage>
            <page-range>159-162</page-range>
            <pub-id pub-id-type="pmid">30166816</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29533.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Herbert</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Kay</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Faustini</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Richter</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Abouelhadid</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cuccui</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wren</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>TJ</given-names>
              </name>
            </person-group>
            <article-title>Production and efficacy of a low-cost recombinant pneumococcal protein polysaccharide conjugate vaccine.</article-title>
            <source>Vaccine</source>
            <year>2018</year>
            <month>Jun</month>
            <day>18</day>
            <volume>36</volume>
            <issue>26</issue>
            <fpage>3809</fpage>
            <page-range>3809-3819</page-range>
            <pub-id pub-id-type="pmid">29778517</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29533.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blot</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pauchard</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Dunn</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Donze</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Malnuit</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rebaud</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Croisier</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Piroth</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pugin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Charles</surname>
                <given-names>PE</given-names>
              </name>
            </person-group>
            <article-title>Mechanical ventilation and Streptococcus pneumoniae pneumonia alter mitochondrial homeostasis.</article-title>
            <source>Sci Rep</source>
            <year>2018</year>
            <month>Aug</month>
            <day>06</day>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>11718</fpage>
            <pub-id pub-id-type="pmid">30082877</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
